mazindol has been researched along with carbidopa in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blunt, SB; Jenner, P; Marsden, CD | 1 |
Halliwell, B; Jenner, P; Lyras, L; McKenzie, G; Pearce, RK; Zeng, BY | 1 |
Fekete, MI; Fülöp, F; Homicskó, KG; Kertész, I; Nagy, GM; Radnai, B; Tóth, BE; Tóth, G | 1 |
3 other study(ies) available for mazindol and carbidopa
Article | Year |
---|---|
The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography.
Topics: Animals; Autoradiography; Brain Tissue Transplantation; Carbidopa; Dopamine; Female; Fetal Tissue Transplantation; Graft Survival; Immunohistochemistry; Levodopa; Mazindol; Rats; Rats, Inbred Strains; Tyrosine 3-Monooxygenase | 1991 |
Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeys.
Topics: Animals; Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cerebral Cortex; Corpus Striatum; DNA Damage; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Levodopa; Macaca fascicularis; Mazindol; Neural Pathways; Nitriles; Oxidative Stress; Reference Values; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |
Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Binding Sites; Binding, Competitive; Brain; Carbidopa; Clonidine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Isoquinolines; Kinetics; Lactation; Levodopa; Male; Mazindol; Median Eminence; Methyldopa; Pituitary Gland; Pituitary Gland, Posterior; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine | 2003 |